It has been generally believed that MOVCin BCS is caused by a congenital vascular malformation. However, the recent pathological study by Kage et al (2) clearly supports the acquired theory which postulates "thrombosis" rather than a "congenital anomaly" as the cause. Prof. Kunio Okuda(3) strongly suggested in his 1982 editorial in Gastroenterology to a paper from South Africa (4) which reiterated the congenital malformation theory and frequent complicating hepatocellular carcinoma, that the pathogenesis of MOVC would be an acquired one for the following reasons : first, this is mainly an adult disease (age, 20-40 years in the majority) and the age of onset is totally incompatible with a congenital disease; second, none of the reported cases of MOVC in Japan had evidence of other congenital abnormalities; and lastly, the types of occlusion in IVChave a wide variety, which is also unusual if it were congenital in etiology. Based on his and other data, Okuda proposed a new classification ofBCS, dividing it into two types (5). One is an "idiopathic" and the other a "secondary" type with an underlying etiology. The former often has a mild clinical presentation with a slow disease progression, probably due to an early development of collaterals that entails a relatively benign prognosis. Most of this type has MOVC. In contrast, the "secondary" type BCS often presents acutely with severe clinical manifestations that follow a sudden thrombotic obstruction of the major hepatic veins, and the prognosis is poor. are believed to be useful in the diagnosis of latent MPD.In this patient, liver transplantation was performed in Australia because brain death is not legally recognized as a biological death in Japan. The first transplantation was a failure due to recurrence of thrombosis as a result of the hypercoagulable state of the patient, as previously experienced (13, 14), but retransplantation was a success as it was combinedwith the administration of hydroxyurea and anticoagulants, such as aspirin and warfarin, a well documented countermeasure in Western countries (14-18).
Although BCSwithout membranous obstruction of IVC secondary to MPDwas rare in Japan in the past, it may increase in the future as disease epidemiology in Japan is slowly approaching that of Western countries. Therefore, the possibility of occult MPDshould always be kept in mind as a possible cause whenone sees a patient with BCSin Japan in the future. In such a case, liver transplantation followed by supportive medical management for MPDwill prove remarkably effective.
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